LEIDEN, The Netherlands,
March 30, 2023 /PRNewswire/ --
Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq:
PHAR) announces that Pharming's Chief Executive Officer, Sijmen de
Vries, and Chief Commercial Officer, Stephen Toor, will attend the Guggenheim
Healthcare Talks | Genomic Medicines and Rare Disease Days,
April 3 - 4, 2023 in New York.
Pharming's CEO and CCO will take part in a fireside chat on
April 3 at 15:20 ET /21:20
CEST.
A live webcast and replay of the fireside
chat can be found in the "Upcoming Events" and
"News" sections of Pharming's website.
Pharming's CEO and CCO will be available for one-to-one investor
meetings during the conference.
For more information about the conference, or to schedule a
one-to-one with Pharming's management team, please contact your
Guggenheim representative, or send an email to Pharming's Investor
Relations team to investor@pharming.com.
About Pharming Group N.V.
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is
a global biopharmaceutical company dedicated to transforming the
lives of patients with rare, debilitating, and life-threatening
diseases. Pharming is commercializing and developing an innovative
portfolio of protein replacement therapies and precision medicines,
including small molecules, biologics, and gene therapies that are
in early to late-stage development. Pharming is headquartered in
Leiden, Netherlands, and has
employees around the globe who serve patients in over 30 markets in
North America, Europe, the Middle
East, Africa, and
Asia-Pacific. For more
information, visit www.pharming.com or follow us on
LinkedIn.
Logo -
https://mma.prnewswire.com/media/1778344/Pharming_Group_NV_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/pharming-to-present-at-the-guggenheim-healthcare-talks--genomic-medicines-and-rare-disease-days-301786073.html